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Erythrocyte Na+ and K+ transport systems in children with Bartter
syndrome: Increase in passive sodium permeability. Na+ and K+
intracellular content was studied in five children with Bartter syndrome
and their age and race-paired controls. Na+ and K+ pump (ouabain
sensitive) fluxes, Na+-K+ co-transport (furosemide sensitive), and
rate constants of passive Na+ and K+ permeability were determined in
each patient and control and also in six parents. The results show that in
Bartter syndrome, there is a significant increase in the rate constant of
passive Na+ permeability without any change in passive K+ perme-
ability. This increase in the rate constant of passive permeability might
explain at least partially the increased intracellular Na+ concentration
also found in these patients. Moreover, the maximal rate of ouabain
sensitive Na+ efflux was increased slightly, and co-transport fluxes
were variable. Parents of patients had normal erythrocyte fluxes.
Etude de divers systèmes de transport du Na+ et du K+ a travers Ia
membrane erythrocytaire chez des enfants souffrant du syndrome de
Bartter: Augmentation spécifique de Ia perméabilite passive du sodium.
La concentration intra-erythrocytaire en Na+ et K+ a eté mesurée
chez cinq enfants souffrant du syndrome de Bartter couples a des
témoins du méme age et de Ia méme race. Les flux de la pompe
sodium (sensibles a la ouabaIne), le co-transport du Na+ et du K+
(sensible a la furosémide) et le taux de perméabilite passive du Na+ et
du K+ ont été déterminés chez chaque patient et leur témoin ainsi que
chez six parents de patients. Nos résultats démontrent que dans le
syndrome de Bartter, le taux de Ia perméabilité passive du Na+ est
élevé par rapport aux témoins, sans élévation toutefois du taux de Ia
perméabilité passive du K+. Cette élévation du taux de Ia perméabilité
passive du Na+ peut expliquer en partie les concentrations intra-
erythrocytaires élevées de Na+ retrouvées chez nos patients. Quant
aux autres systèmes de transport, nos patients présentaient un taux
maximal d'efflux de Na+ sensible a La ouabaine légèrement élevé et des
flux des au co-transport variables. Les flux de Na+ et K+ chez les
parents de patients étaient normaux.
Since the original description by Bartter in 1962 [1] of the
syndrome consisting of normal blood pressure, hypokalemic
alkalosis, hyperreninism, juxtaglomerular hyperplasia, hyperal-
dosteronism, and elevated plasma angiotensin II with resistance
to angiotensin II pressor action, additional features have been
described. Some are constantly present, such as impairment of
concentrating ability [21, elevated prostaglandin levels in the
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blood [3—6] and urine [7, 8], while others are inconstantly
observed such as hypomagnesemia [91, tubular acidosis [10],
Fanconi syndrome [11, 12], and chondrocalcinosis [9, 13]. The
extension of the disease spectrum has complicated the search
for a single etiologic primary defect. The specific tubular defect
in Bartter syndrome has been a subject of some controversy.
Originally, this defect was thought to be exclusively a reabsorp-
tive defect of sodium at the proximal site [14]. More constant,
however, is finding the defect in chloride reabsorption in the
ascending loop of Henle [1, 3, 15] with elevated potassium loss
in the urine. Hyperreninism, hyperaldosteronism, and hyper-
prostaglandinism appear to be secondary phenomena in the
disease. Because some familial cases of Bartter syndrome have
been reported [16] and because altered cellular active sodium
reabsorption was suggested, a generalized membrane defect
was looked for in red blood cells and skeletal muscle mem-
branes of patients with the disease and their relatives [17—21].
As suggested by Parker [22] in a recent editorial, an abnormal
transport system found in erythrocytes may indicate a general-
ized transport disorder in other cell series.
New techniques have been adopted recently to the clinical
investigation of cation transport across erythrocyte membranes
[23—26]. They have permitted the study of several Na+ and K+
transport systems in erythrocytes, particularly in essential
hypertension [26—28]. These techniques have been modified
further to obtain better specificity and reproducibility [24].
A better knowledge utilizing more specific investigative tech-
niques for studying erythrocyte cation transport systems might
aid in defining the primary defect in Bartter syndrome. The
purpose of our project is to study Na+ and K+ efflux due to the
Na+ and K+ pump (ouabain sensitive), the Na+ and K+ co-
transport (furosemide sensitive), and passive permeability of
erythrocytes of children suffering from Bartter syndrome.
Methods
Five boys, age 6 months to 14 years, known to be typical
patients with Bartter syndrome according to all the criteria
originally described by Bartter were the subjects of this study.
These patients presented all the features of the syndrome
summarized recently [29]: onset in infancy, no history of
chronic vomiting, negative investigation for cystic fibrosis,
chronic alkalosis with hypochloremia, hypokalemia, normal
blood pressure, growth retardation, normal plasma creatinine, a
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urine concentrating defect, hyperreninism, hyperaldosteron-
ism, hyperprostaglandinism, and partial response to indometh-
acm therapy. In four of the five patients (numbered 2, 3, 4, 5), a
kidney biopsy was performed and showed hyperplasia of the
juxtaglomerular apparatus. The same four patients also showed
resistance to pressor effects of angiotensin II. They also had
urinary potassium and chloride wastage and a vasopressin-
resistant urinary concentrating defect. Because in four patients,
original investigations establishing the diagnosis had been done
several years ago, even before the concept of a distal chloride
reabsorption defect was suggested as the cause of the disease,
this specific defect was not looked for in these patients. The
diagnosis however was based on the original parameters report-
ed in the literature on this entity, and other causes of hypokale-
mia could be ruled out. The patients were not receiving any
form of treatment at the time studies were performed. Other
biochemical parameters such as serum electrolytes, plasma
creatinine, and blood smear were performed at the time blood
samples were obtained for Na+-K+ flux studies.
Two patients were black and three were white. Hypokalemia
varied from 2.5 to 3.1 mEqfliter at the time studies were
performed. All patients had hemoglobin values within normal
limits but all had a mean corpuscular volume varying from 0.65
to 0.79 d (normal: 0.80 to 0.95 1.d). In two patients, the total
erythrocyte volume was measured and found to be decreased
by 20% of normal values. The controls were paired for age and
race and consisted of children admitted for orthopedic or
psychological therapy and were not receiving any medication at
the time of the study. None of these controls had electrolyte
abnormalities or had hypertensive parents.
Six healthy parents of patients, four mothers and two fathers,
agreed to venepuncture so that their erythrocyte fluxes could be
measured.
Techniques
(1) Intracellular Na+ and K+ contents were determined
according to the technique of Smith and Samuel [301.
(2) Na+ and K+ fluxes catalyzed by the Na+-K+ pump,
Na+ and K+ co-transport and Na+ and K+ passive permeabil-
ity were measured in erythrocytes according to the technique
already described by our group [241. This procedure may be
summarized as follows: Freshly drawn venous blood (10 ml)
was collected in heparinized tubes. It was centrifuged immedi-
ately, the plasma and buffy coat were removed, and erythro-
cytes were washed twice in 150 mmoles sodium chloride at 4°C.
The washed red cells were then loaded with Na+ and choline
and depleted of K+ by suspension for 20 hr in a "loading
medium" containing 50 mmoles of sodium chloride, 3 mmoles
of potassium chloride, 200 mmoles of choline chloride, 2.5
mmoles of sodium phosphate, 1 mmole of magnesium chloride,
1 mmole of EGTA, and 0.02 mmole of 2.5-p-chloromercuriben-
zenesuiphonate (PCMBS). The presence of hypertonic choline
chloride in the loading medium ensures the entry of a sufficient
amount of choline into the cells to prevent cell shrinkage by K+
depletion. Cells were then centrifuged at x 1750g at 4°C for 10
mm and the supernatant was discarded. Cells were then incu-
bated for 1 hr at 37°C in a "recovering medium" containing 150
mmoles of sodium chloride, 1 mmole of magnesium chloride,
5.4 mmoles of sodium phosphate buffer (pH 7.4, 37°C), 4
mmoles of cysteine, 2 mmoles of adenine, 3 mmoles of inosine,
and 10 mmoles of glucose. Cells were then washed six times in a
cold solution of 110 mmoles of magnesium chloride, and re-
suspended in magnesium-sucrose medium to obtain a hemato-
crit of 50 to 60%. Hematocrit, intracellular Na+, K+, and
hemoglobin were measured in a separate aliquot.
One milliter of cell suspension was added to 15 ml of three
different media of magnesium-sucrose, one containing potassi-
um chloride (K+ medium), one containing 0.1 mmole ouabain
(ouabain medium), and one containing ouabain plus furosemide
(furosemide medium). The final hematocrit was 3 to 4%. The
magnesium-sucrose media contained 75 mmoles/liter of MgCl2,
85 mmoles/liter sucrose, 5 mmoles/liter of glucose and 10
mmoles/liter of MOPS-TRIS (ph 7.2 at 37°C). Each resulting
suspension was pipetted into six tubes and incubated at 37°C
with continuous agitation. Two tubes incubated in "K+ medi-
um" were removed at 15, 30, and 45 mm, respectively. Two
tubes containing either "ouabain" or "furosemide" medium
were removed at 30, 60, and 90 mm. The tubes were then
transferred to 0°C for I mm and spun at 4°C and x 1750g for 3
mm. The supernatant was removed carefully and its Na+ and
K+ content measured by flame photometry.
Data relating extracellular Na+ and K+ concentrations as a
function of time were subjected to linear regression analysis.
The effiux (in imoles/liter of cells/hour) was obtained by
dividing the regression slope by the final hematocrit. The Na+-
K+ pump fluxes (ouabain sensitive) were obtained by subtract-
ing the efilux value in the ouabain medium from that in the
potassium medium. The Na+ and K+ co-transport efflux
(furosemide sensitive) was obtained by subtracting the effiux
value in the "furosemide medium" from that in the "ouabain
medium." The rate constant of passive Na+ and K+ perme-
ability was calculated by dividing the ouabain and furosemide
resistant Na+ or K+ efflux by the postloading intracellular
concentration of Na+ or K±.
(3) To assess the possible influences of cell volume upon
Na+-K-fluxes, erythrocyte water content was determined in
one instance according to the technique already reported from
our laboratory [311. Also, fluxes were measured simultaneously
on cells obtained from one patient, both in regular incubation
medium and cells shrunken by hypertonic medium where 150
mmoles of sucrose were added to increase the osmolarity.
Results
Intracellular cation content. In patients with Bartter syn-
drome, the intracellular Na+ concentration was much higher
than that of their controls, as seen in Table 1. The intracellular
K+ content of patients was lower than that of controls, but the
difference was not significant. Some of the values of intracellu-
lar K+, particularly for patient 1 and controls 1 and 5are high;
we have no explanation for these findings other than the
average intracellular potassium value is high in our laboratory.
The small number of controls in the pediatric age group might
partially explain these results.
Na+ and K+ fluxes. After loading the cells, both patients
and controls had an intracellular Na+ concentration of 42.7
mmoles/liter (SD 2) of cells and a K+ concentration of 53
mmoles/liter (SD 5) of cells. The presence of choline inside
the cells preserved a normal cell volume as shown by the
constant hemoglobin concentration before and after loading.
The postloading mean value of hemoglobin concentration was
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Table 1. Erythrocyte cation concentration and transport in children with Bartter syndrome and their age-paired controls
Patient I
Control 1
Patient 2c
Control 2
Patient 3a
Patient 4
Control 4
Patient 5
Control 5
Symbol: ( ), SEM.
a In mmoles/liter of cells.
In .tmoles/liter of cells/hour.
Patients 2 and 3 were black male children and the same control was used for both.
Maximal rate of
ouabain sensitive
Na+ efflux
Maximal rate of furosemide
sensitive efflux5
Na+ K+
8000
7000
Na K 6000
6000
Pump
4000
3000
Age Intracellular Intracellular
years Na+a K+a
13
14
1 Patients
5 Controls
0.5 9.93
10.3
127.4
118.1
7798
4347
277
266
276
275
8 19.51
11.9
99
101
5177
4003
0
255
162
390
8 39.1 87 6126 0 292
—
10.7
—
105.3
5655
3790
754
307
591
507
16.2
9.9
101.5
114.5
5848
8578
294
320
594
362
21.2
10.7
(6.3)
(0.4)
103.7 (8.5)
109.7 (3.9)
6121 (447)
5179 (1138)
265 (138)
287 (16)
383 (88)
384 (48)
Otol Year ltol4Years Adults
.
.
.
.
.
.
5.3 mmoles/liter of cells as compared to the preloading mean
value of S mmoles/liter of cells.
Figure 1 depicts the values of controls obtained related to
age. It is obvious from these results that passive Na+ and K+
permeabilities are not influenced by age. For Na+ pump fluxes,
and more obviously for co-transport fluxes, the values appear
to increase with age. The limited number of children reported in
this figure does not permit us to conclude that the maturation
process of these transport systems is a function of age, but only
suggests such a process, and led us to compare values of
patients with age-paired controls instead of reporting means of
groups.
The maximal rate of ouabain sensitive Na+ efflux catalyzed
by the Na+ pump is reported in Table 1. It is elevated in
patients with Bartter syndrome (mean, 6116 j.moles/liter of
cells/hour) when compared to controls (mean, 5062 moles/liter
of cells/hour). This difference however is not statistically
significant.
Na+ and K+ co-transport fluxes are also presented in Table
1. There is no constant difference between patients and their
controls. Furosemide sensitive Na+ efflux was 0 in two pa-
tients. These values are possibly related to the fact that these
patients were black and recent results from our laboratory
indicate a high frequency of nondetectable Na+ co-transport
fluxes in the black population [321.
Passive Na+ and K+ permeabilities are reported in Table 2.
Passive Na+ permeability was elevated significantly in patients
relative to controls, and even with the small sample size, this
difference reached significance with aP value <0.05. The mean
passive K+ permeability was similar in the two groups. Thus,
the increase in passive Na+ permeability cannot be attributed
solely to a greater surface/volume ratio in patients' erythrocytes
as a parallel increase in passive K+ permeability was not
observed.
Parents. Erythrocyte cation content and transport of parents
Co.transport 900 U
800
700
. U
•Na
600
. .
.UK 500 U ••••
400
300 • •
. •U .
. .
.
•.
200
•
U
• S
.
..U • U
.
Passive
permeability 20
10
NsF
K 10
5
Fig. 1. Na + and K+ transport of normotensive controls according to
age. Na+-K+ pump refers to the maximal rate of ouabain sensitive
Na+ efflux. Na+-K+ co-transport indicates maximal rate of furose-
mide-sensitive Na+ and K+ efflux. Symbols: *, Amoles/liter of cells/hour; , rate constant in h' x iO.
of patients with Bartter syndrome are shown in Table 3.
Intracellular Na+ concentration was higher than normal in one
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Na+
No.a Patients Controls Patients Controls
1 0.039 0.018 0.009 0.006
2 0.018 0.015 0.011 0.007
3 0.023 0.015 0.009 0.007
4 0.031 0.019 0.006 0.008
5 0.023 0.011 0.010 0.017
0.0090.027' 0.016 0.009
a No. refers to numbers in Table 1.
P < 0.05.
black parent (mother no. 3), but normal values for blacks are
not conclusive. The Na+-K+ pump fluxes and passive permea-
bilities were normal for all the parents of patients. Co-transport
fluxes were lower than normal for three out of six parents
(mothers 3, 4, 5). In the three instances, a history of essential
hypertension was found in the family. This co-transport value
could be the result of an hereditary trait [271.
Special studies. Passive Na+ and K+ permeabilities were
not significantly different in fresh cells compared to PCMBS-
treated cells, as previously reported [331.
In one patient, Na+ and K+ fluxes were measured simulta-
neously in isotonic and hypertonic media. Hypertonicity of the
incubation medium showed mild non-significant effects on Na+
and K+ fluxes. It decreased the N+-K+ pump fluxes (5848 to
4729 tmoles/liter of cells/hour), increased the Na+ co-transport
flux (294 to 477 moles/liter of cells/hour), increased the K+
co-transport flux (594 to 622 moles/liter of cells/hour), and
increased both Na+ and K+ passive permeabilities from 0.0227
to 0.0455 and from 0.0096 to 0.0126, respectively. The Na+ and
K+ co-transport fluxes were 294 and 594 jmoles/liter of cells in
isotonic medium. This difference shows a partial uncoupling of
the two systems in our experimental conditions. The values of
477 and 622 .tmoles/liter of cells, respectively, found in a
hypertonic medium partially reduces this uncoupling
phenomena.
The intracellular water content of fresh cells from this patient
was found to be 65% which was within normal values. As
shown by Adragna et al [34], the dependence of Na+-K+ co-
transport fluxes on cell volume in human red blood cells is
different from that previously observed in avian red cells.
Discussion
The results of this study indicate that patients with Bartter
syndrome have an increased intracellular Na+ concentration
and an increased passive Na+ permeability. In addition, the
maximal rates of pump fluxes were increased slightly and Na+
and K + co-transport fluxes were variable.
Values of intracellular Na+ concentration in erythrocytes of
normal persons are reported to vary from 6 to 12 mEq/liter cells
in various studies. This great fluctuation obviously results
mainly from the differences in the technique employed for the
determination of Na+ content. However, other factors might
influence individual values such as race and age. Racial differ-
ences in erythrocyte Na+ transport indeed were reported
recently [32] in normotensive and hypertensive adults. Erythro-
cyte Na+ concentration was also found to be more elevated in
normal young infants with a maximum around the age of 3
months and then slowly decreasing to adult's values obtained
around age 10 [35]. In that study, decreased ATPase activity
was parallel to Na+ concentration. Such fluctuations might
explain why in various studies including the present one, a
control might occasionally have erythrocyte Na+ concentra-
tion as high as a patient, and stress the importance to use age-
and race-paired controls. The increased intracellular Na+
found in children with Bartter syndrome in this study is in
agreement with previous reports [17, 18, 20, 21]. However,
there is no agreement between the different investigators con-
cerning the various transport mechanisms responsible for such
elevated values of intracellular sodium. Gall et al [171 reported
an increased Na+ pump flux whereas in the studies reported by
Gardner et al [18] fractional Na+ efflux was significantly less
than normal. Oliver, Delaney, and Bourke [20] agree that in
Bartter syndrome, ouabain resistant Na+ efflux was increased,
but their results do not further differentiate between ouabain
resistant efflux due to the co-transport system, and that due to
passive permeability. Cole and O'Regan [21] reported that
patients with Bartter syndrome have a higher passive sodium
leak than controls. The specific increase in passive sodium
permeability found in the present study most likely represents
the same conclusion as their findings. Moreover, the previously
quoted studies [18, 20] have contradicting results concerning
the erythrocyte transport systems of parents of patients with
Bartter syndrome.
In all other studies, erythrocytes were not loaded with
sodium as much as in this study, and the intracellular content of
sodium of the cell suspension used for flux measurement is
unknown. Garay and Garrahan [36] demonstrated that the Na+
efflux is proportional to the increase in Na+ concentration.
This efflux reaches maximal rate when the intracellular Na+
concentration reaches 25 mmoles/liter of cells. Loading the
cells to elevate the intracellular concentration of Na+ above 25
mmoles/liter thus allows an accurate comparison of the maxi-
mal rate of fluxes in Bartter syndrome patients and controls.
The actual concentration of intracellular sodium is the result
of the different transport systems operating at the level of
human red blood cell membrane. Only recently the kinetics of
these various transport systems characterized [371. This study
was thus undertaken with a better insight into the various
systems which could implicate abnormalities in cation exchange
in Bartter syndrome. The main explanation for the increased
intracellular sodium content found in this study is a specific
increase in sodium passive permeability. These results extend
the previous attempts of Gall et al [17] and Cole and O'Regan
[21] with more precise techniques to measure various cation
transport pathways.
In our experimental conditions, maximal ouabain sensitive
Na+ extrusion was increased as expected from the study of
Erdmann, Krawietz, and Koch [38] showing that in every
disease producing chronic hypokalemia and including Bartter
syndrome, the number of ouabain binding sites is increased.
However, it is not certain that this same situation exists in vivo
in Bartter syndrome, because of the countervailing effects of
raised intracellular Na+ causing an increase, and extracellular
hypokalemia causing reduced Na+ pump activity [36, 39].
Thus, when these opposing factors are considered, it would
Table 2. Rate constant of passive Na+ and K+ permeabilities
534 Mongeau et al
Table 3. Cation content and transport of relatives of children with Bartter syndrome
Maximal rate of
Relativea
Intracellular
Na+
contentb
Maximal rate of
ouabain sensitive
Na+ effluxc
furosemide sensitive
efflux
Na+ K+
Rate constant of passive
permeability
Na+ K+
Mother 1 9.4 5105 455 338 0.008 0.004
Father 1 6.5 7939 375 445 0.015 0.007
Mother 3" 15.3 3743 150 313 0.019 0.009
Mother 4 — 4788 262 188 0.013 0.006
Mother 5 8.2 6564 88 148 0.017 0.009
Father 5 9.4 5198 480 483 0.022 0.008
a The number following the parent corresponds to the number of the patient in previous tables.
b Expressed in mmoles/liter of cells.
Expressed in moles/liter of cells/hour.
Black mother.
appear that the Na+-K+ pump in vivo is not different from
controls.
The other transport system measured in the present study,
the co-transport system, does not show any consistent alter-
ation: Several factors may contribute to this variability: ethnic
factors [32] and heredity [27] have already been reported.
Chronic hypokalemia [331 and hypochloremia [40, 411 may
influence co-transport fluxes in vivo and are constantly found in
Bartter syndrome.
However, the increase in intracellular sodium content could
also be partially explained as a secondary phenomenon due to
chronic hypokalemia and increased Na+ bicarbonate exchange
at the level of the red blood cells, not measured in this study,
but well known to occur in any state of chronic alkalosis [421.
The primary defect of a selective increase in Na+ passive
permeability in Bartter syndrome is not observed in the parents
of the patients in this study. These results are not in contradic-
tion with the ones of Gardner et al [18] since, in the former
study, the rate constant of Na+ passive permeability was not
measured and moreover, the intracellular Na+ content of the
relatives in their study was found not to be different from their
controls.
The assumption of Parker [22] that a transport defect found in
erythrocytes may occur at the level of other cells may be
applied to Bartter syndrome. There is a specific Na+ perme-
ability in erythrocytes of patients with Bartter syndrome. Even
if we are unable at the moment to relate this abnormality to the
renal tubular transport defect, the presence of a generalized
membrane defect is still possible.
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